Live RSS
Federal Grant · National Institutes of Health

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.

BiotechHealthcare Tech university-researcherindividual-researchernon-profit
The pitch

If you're a researcher with lab capacity investigating the biological roots of cancer disparities, this multi-year R01 provides sustained funding with minimal clinical trial restrictions.

Award range
Unspecified
Closes
Jan 7, 2028 · 618d left
Open date
Nov 18, 2024
Difficulty
High
Source
Grants.gov
Agency
National Institutes of Health
Last verified
2026-04-29
Fit language
Possible fit only
Apply at grants.gov →

Report stale or inaccurate summary

What this is

This R01 grant from the National Cancer Institute (CFDA 93.393) funds fundamental research into biological and genetic mechanisms underlying cancer health disparities—not clinical trials. Eligible projects include mechanistic studies of cancer biology, development of new research models and tools (biospecimens, patient-derived models), and secondary data analyses. The program explicitly seeks to grow a nationwide cohort of basic researchers with deep expertise in cancer disparities, expanding the resource base for future research.

Who can apply

Extremely broad: universities (public and private), nonprofits with 501(c)(3) status, small businesses, state/local governments, tribal governments, and for-profit organizations. Solo researchers must be affiliated with an eligible institution. No geographic restrictions.

Eligible applicant types

Full description — from the agency

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This NOFO is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.

Topics: cancer health disparities · basic research grants · mechanistic biology · cancer genetics · NIH R01 · biospecimen development

Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.